Requena C, Alsina M, Morgado-Carrasco D, et al. Sarcoma de
Kaposi y angiosarcoma cutáneo: directrices para el
diagnóstico y tratamiento. Actas...
Requena C, Sendra E, Llombart B, et al. Angiosarcoma cutáneo:
estudio clínico-patológico de 16 casos. Actas Dermosfiliogr.
2017;108:457–465.
Trofymenko O, Curiel-Lewandrowski C. Surgical treatment
associated with improved survival in patients with cutaneous
angiosarcoma. J Eur Acad...
Sinnamon AJ, Neuwirth MG, McMillan MT, et al. A prognostic
model for resectable soft tissue and cutaneous angiosarcoma.
J Surg Oncol. 2016;114:557–563.
Fujisawa Y, Yoshino K, Fujimura T, et al. Cutaneous
angiosarcoma: the possibility of new treatment options
especially for patients with large...
Ishida Y, Otsuka A, Kabashima K. Cutaneous angiosarcoma:
update on biology and latest treatment. Curr Opin Oncol. 2018;
30:107–112.
Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP.
Cutaneous angiosarcoma: a current update. J Clin Pathol. 2017;
70:917–925.
Grobmyer SR, Daly JM, Glotzbach RE, Grobmyer AJ 3rd. Role of
surgery in the management of postmastectomy extremity
angiosarcoma (Stewart-Treves...
Buehler D, Rice SR, Moody JS, et al. Angiosarcoma outcomes
and prognostic factors: a 25-year single institution experience.
Am J Clin Oncol....
Repiso B, Pérez-Gil A, Argueta O, Ríos JJ, Sotillo I, Camacho F.
Angiosarcoma de cara y cuero cabelludo. A propósito de un
caso. Actas Dermosifiliogr....
Co M, Lee A, Kwong A. Cutaneous angiosarcoma secondary to
lymphoedema or radiation therapy – a systematic review. Clin
Oncol. 2019;31:225–231.
Nespereira-Jato MV, Peña-Panabad C, Quindós-Varela M,
García-Silva J. Angiosarcoma irresecable tratado con
bevacizumab y paclitaxel. Actas...
Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel
for unresectable angiosarcoma: the ANGIOTAX study. J Clin
Oncol. 2008;26:5269–5274.
Rodríguez-Bujaldón A, Vázquez-Bayo MC, et al. Angiosarcoma
sobre linfedema crónico. Actas Dermosifiliogr. 2006;97:525–528.
Ray-Coquard I, Italiano A, Bompas E, et al. French Sarcoma
Group (GSF/GETO). Sorafenib for patients with advanced
angiosarcoma: a phase II...
Maki RG, D’Adamo DR, Keohan ML, et al. Phase II study of
sorafenib in patients with metastatic or recurrent sarcomas. J
Clin Oncol. 2009;27:3133–3140.
Kollár A, Jones RL, Stacchiotti S, et al. Pazopanib in advanced
vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma
Group (STBSG) retrospective...
Kitamura S, Yanagi T, Inamura Y, et al. Pazopanib does not
bring remarkable improvement in patients with
angiosarcoma. J Dermatol. 2017;44:64–67.
Liu M, Liu Y, Guo H, et al. Apatinib, combined with
chemotherapy or alone is effective in treating angiosarcoma: a
case report. Anticancer...
Agulnik M, Yarber JL, Okuno SH, et al. An open-label,
multicenter, phase II study of bevacizumab for the treatment
of angiosarcoma and epithelioid...
Fujimura T, Sato Y, Kambayashi Y, et al. Three patients with
advanced cutaneous angiosarcoma treated with eribulin:
investigation of serum...
Wada N, Uchi H, Furue M. Case of angiosarcoma of the scalp
successfully controlled by eribulin. J Dermatol. 2018;45:116–117.
Florou V, Rosenberg AE, Wieder E, et al. Angiosarcoma
patients treated with immune checkpoint inhibitors: a case
series of seven patients...
Hofer S, Zeidler K, Schipf A, Kempf W, Zimmermann D, Aebi S.
Angiosarcoma of the scalp responding to nivolumab: a case
report. Br J Dermatol....
Gao Y, Wang WS, Wang HL, Liu J, Lu YG. Treatment of
Epithelioid angiosarcoma with Topical ALA-PDT in the course
of surgery. Photodiagnosis...
Stiles JM, Amaya C, Rains S, et al. Targeting of beta adrenergic
receptors results in therapeutic efficacy against models of
hemangioendothelioma...
Amaya CN, Perkins M, Belmont A, et al. Non-selective beta
blockers inhibit angiosarcoma cell viability and increase
progression free- and...
Pasquier E, André N, Street J, et al. Effective management of
advanced angiosarcoma by the synergistic combination of
propranolol and vinblastine-based...